Ketamine Alleviates Depressive-Like Behaviors via Down-Regulating Inflammatory Cytokines Induced by Chronic Restraint Stress in Mice
Open accessAbstract
The purpose of the present study was to investigate whether ketamine's rapid antidepressant effects were associated with its anti-inflammatory actions and to explore the underlying molecular mechanism. Depressive-like behaviors was induced in mice using chronic restraint stress (CRS) method. Anti-depressive effects of ketamine were evaluated by forced swimming tests (FST) and sucrose preference test (SPT). Subsequently, brain tissue was harvested to investigate inflammatory response in the hippocampus via investigating reactive microglia numbers, serum cytokines levels and the toll-like receptor type 4 (TLR4)/p38 mitogen-activated protein kinase (MAPK) pathway. CRS exposure caused depressive-like behaviors in mice, which was associated with increased pre-inflammatory cytokines (interleukin (IL)-1β, tumor necrosis factor (TNF)-α and IL-6) levels, reactive microglia numbers and up-regulated regulatory molecules such as TLR4/p38 and P2X7 receptor in hippocampus. Such neurobehavioral and biochemical abnormalities were normalized by ketamine treatment. CRS-induced depression-like behaviours are associated with activation of hippocampal inflammatory response, whereas down-regulation of pro-inflammatory cytokines may contribute to ketamine's antidepressant effects in mice.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The antidepressant-like effect induced by clemasine and ketamine was associated with decreased hippocampal P2X7R levels in stressed mice.
“Moreover, the antidepressant-like effect induced by clemasine [80] and ketamine [81] were associated with decreased hippocampal P2X7R levels in the in stressed mice.”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [81]
Exposure of mice to chronic restraint stress increased hippocampal P2X7R levels.
“and exposure of mice to chronic restraint stress (CRS) increased hippocampal P2X7R levels [81].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [81]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Projections of Global Mortality and Burden of Disease from 2002 to 2030
Mathers, C. D., & Loncar, D. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030442 · Cited by 11,386 · see citing works
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · see citing works
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · see citing works
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881 · see citing works
Willner, P., Towell, A., Sampson, D., Sophokleous, S., & Muscat, R. (1987) · Psychopharmacology · doi:10.1007/bf00187257 · Cited by 1,993 · see citing works
Regulation of the Hypothalamic‐Pituitary‐Adrenocortical Stress Response
Herman, J. P., McKlveen, J. M., Ghosal, S., Kopp, B., Wulsin, A., Makinson, R., Scheimann, J., & Myers, B. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c150015 · Cited by 1,819 · see citing works
Li, N., Liu, R.-J., Dwyer, J. M., Banasr, M., Lee, B., Son, H., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.12.015 · Cited by 1,082 · see citing works
Zarate, C. A., Brutsche, N. E., Ibrahim, L., Franco-Chaves, J., Diazgranados, N., Cravchik, A., Selter, J., Marquardt, C. A., Liberty, V., & Luckenbaugh, D. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.010 · Cited by 811 · see citing works
Steiner, J., Bielau, H., Brisch, R., Danos, P., Ullrich, O., Mawrin, C., Bernstein, H.-G., & Bogerts, B. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.10.013 · Cited by 791 · see citing works
Chiba, S., Numakawa, T., Ninomiya, M., Richards, M. C., Wakabayashi, C., & Kunugi, H. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.05.018 · Cited by 673 · see citing works
Cytokine activation of the HPA axis
DUNN, A. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05426.x · Cited by 352 · see citing works
Zunszain, P. A., Hepgul, N., & Pariante, C. M. (2012) · Current topics in behavioral neurosciences · doi:10.1007/7854_2012_211 · Cited by 317 · see citing works
Yao, L., Kan, E. M., Lu, J., Hao, A., Dheen, S. T., Kaur, C., & Ling, E. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-23 · Cited by 296 · see citing works
Dale, O., Somogyi, A. A., Li, Y., Sullivan, T., & Shavit, Y. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3182662e30 · Cited by 238 · see citing works
Voorhees, J. L., Tarr, A. J., Wohleb, E. S., Godbout, J. P., Mo, X., Sheridan, J. F., Eubank, T. D., & Marsh, C. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058488 · Cited by 236 · see citing works
Inflammatory mechanisms in major depressive disorder
Raedler, T. J. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32834b9db6 · Cited by 213 · see citing works
Microglia of Prefrontal White Matter in Suicide
Schnieder, T. P., Trencevska, I., Rosoklija, G., Stankov, A., Mann, J. J., Smiley, J., & Dwork, A. J. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000107 · Cited by 202 · see citing works
Microglia: Proliferation and activation driven by the P2X7 receptor
Monif, M., Burnstock, G., & Williams, D. A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.06.021 · Cited by 196 · see citing works
Cheng, Y., Pardo, M., Armini, R. D. S., Martinez, A., Mouhsine, H., Zagury, J.-F., Jope, R. S., & Beurel, E. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.12.012 · Cited by 174 · see citing works
HSP60 plays a regulatory role in IL-1β-induced microglial inflammation via TLR4-p38 MAPK axis
Swaroop, S., Sengupta, N., Suryawanshi, A. R., Adlakha, Y. K., & Basu, A. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0486-x · Cited by 132 · see citing works
McQuillin, A., Bass, N. J., Choudhury, K., Puri, V., Kosmin, M., Lawrence, J., Curtis, D., & Gurling, H. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.6 · Cited by 117 · see citing works
Zeng, K.-W., Zhang, T., Fu, H., Liu, G.-X., & Wang, X.-M. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.05.030 · Cited by 116 · see citing works
Boucher, A. A., Arnold, J. C., Hunt, G. E., Spiro, A., Spencer, J., Brown, C., McGregor, I. S., Bennett, M. R., & Kassiou, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.049 · Cited by 108 · see citing works
Inhibitory Effects of Ketamine on Lipopolysaccharide-Induced Microglial Activation
Chang, Y. F., Lee, J.-J., Hsieh, C., Hsiao, G., Chou, D., & Sheu, J. (2009) · Mediators of Inflammation · doi:10.1155/2009/705379 · Cited by 108 · see citing works
Stress-induced cytokine changes in rats
Himmerich, H., Fischer, J., Bauer, K., Kirkby, K. C., Sack, U., & Krügel, U. (2013) · European Cytokine Network · doi:10.1684/ecn.2013.0338 · Cited by 107 · see citing works
The Epidemiology of Depression and the Evolution of Treatment
Hirschfeld, R. M. A. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11096su1c.01 · Cited by 100 · see citing works
Xu, Y., Sheng, H., Tang, Z., Lu, J., & Ni, X. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.04.017 · Cited by 94 · see citing works
P2X7 as a new target for chrysophanol to treat lipopolysaccharide-induced depression in mice
Zhang, K., Liu, J., You, X., Kong, P., Song, Y., Cao, L., Yang, S. T., Wang, W., Fu, Q., & Ma, Z. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.043 · Cited by 90 · see citing works
Accelerating response to antidepressant treatment in depression: a review and clinical suggestions.
Nakajima, S., Suzuki, T., Watanabe, K., Kashima, H., & Uchida, H. (2010) · Progress in Neuro-psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.12.001 · Cited by 78 · see citing works
Inflammatory Markers and the Pathogenesis of Pediatric Depression and Suicide
Kim, J.-W., Szigethy, E., Melhem, N., Saghafi, E. M., & Brent, D. A. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08898 · Cited by 76 · see citing works
Neuroinflammation and Depression
Sublette, M. E., & Postolache, T. T. (2012) · Psychosomatic Medicine · doi:10.1097/psy.0b013e318268de9f · Cited by 75 · see citing works
Chang, H.-C., Lin, K.-H., Tai, Y., Chen, J.-T., & Chen, R. (2010) · Shock · doi:10.1097/shk.0b013e3181c3cea5 · Cited by 74 · see citing works
Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
Schmidt, F. M., Kirkby, K. C., & Lichtblau, N. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160115130414 · Cited by 72 · see citing works
Chen, T.-L., Chang, C., Lin, Y., Ueng, Y., & Chen, R. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.06.013 · Cited by 58 · see citing works
Sugama, S., Takenouchi, T., Fujita, M., Kitani, H., & Hashimoto, M. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.11.002 · Cited by 55 · see citing works
Depression Risk in Patients with Rheumatoid Arthritis in the United Kingdom
Jacob, L., Rockel, T., & Kostev, K. (2017) · Rheumatology and Therapy · doi:10.1007/s40744-017-0058-2 · Cited by 52 · see citing works
Effects of Ketamine on Endotoxin and Traumatic Brain Injury Induced Cytokine Production in the Rat
Ward, J. L., Harting, M. T., Cox, C. S., & Mercer, D. (2011) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0b013e31821c38bd · Cited by 46 · see citing works
Matsuwaki, T., Eskilsson, A., Kugelberg, U. Ö., Jönsson, J., & Blomqvist, A. G. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.03.015 · Cited by 45 · see citing works
Endocrine and Neurobehavioral Abnormalities Induced by Propofol Administered to Neonatal Rats
Tan, S., Xu, C., Zhu, W., Willis, J., Seubert, C. N., Gravenstein, N. L., Sumners, C., & Martynyuk, A. E. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000366 · Cited by 39 · see citing works
Depression Epidemiology and Its Treatment Evolution
Hirschfeld, R. M. A. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11096tx3c · Cited by 32 · see citing works
Yuhas, Y., Ashkenazi, S., Berent, E., & Weizman, A. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.03.012 · Cited by 28 · see citing works
Shen, T., Lin, C., Liao, C. H., Wei, C.-C., Fc, S., & Kao, C.-H. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000664 · Cited by 23 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- Nakajima S, Suzuki T, Watanabe K, Kashima H, Uchida H. Accel- erating response to antidepressant treatment in depression: a review and clinical suggestions. Prog. Neuropsychopharmacol. Biol. Psy- chiatry, 34, 259-264 (2010). · DOI
- Chang Y, Lee JJ, Hsieh CY, Hsiao G, Chou DS, Sheu JR. Inhibitory effects of ketamine on lipopolysaccharide-induced microglial acti- vation. Mediators Inflamm., 2009, 705379 (2009). · DOI
- Jacob L, Rockel T, Kostev K. Depression risk in patients with rheumatoid arthritis in the United Kingdom. Rheumatol. Ther., 4, 195-200 (2017). · DOI
- Voorhees JL, Tarr AJ, Wohleb ES, Godbout JP, Mo X, Sheridan JF, Eubank TD, Marsh CB. Prolonged restraint stress increases IL-6, reduces IL-10, and causes persistent depressive-like behavior that is reversed by recombinant IL-10. PLOS ONE, 8, e58488 (2013). · DOI · Paper page
- Schnieder TP, Trencevska I, Rosoklija G, Stankov A, Mann JJ, Smi- ley J, Dwork AJ. Microglia of prefrontal white matter in suicide. J. Neuropathol. Exp. Neurol., 73, 880-890 (2014). · DOI · Paper page
- Zhang K, Liu J, You X, Kong P, Song Y, Cao L, Yang S, Wang W, Fu Q, Ma Z. P2X7 as a new target for chrysophanol to treat lipopolysaccharide-induced depression in mice. Neurosci. Lett., 613, 60-65 (2016). · DOI
Cited by
Sorted by citations
Microglia in depression: an overview of microglia in the pathogenesis and treatment of depression
Wang, H., He, Y., Sun, Z., Ren, S., Liu, M., Wang, G., & Yang, J. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02492-0 · Cited by 591 · see citing works
Neurobiology of Resilience: Interface Between Mind and Body
Cathomas, F., Murrough, J. W., Nestler, E. J., Han, M.-H., & Russo, S. J. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.04.011 · Cited by 296 · see citing works
Chronic stress increases metastasis via neutrophil-mediated changes to the microenvironment
He, X., Gao, Y., Ng, D., Michalopoulou, E., George, S., Adrover, J. M., Sun, L., Albrengues, J., Daßler‐Plenker, J., Han, X., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.01.013 · Cited by 307 · see citing works
Microglia in depression: current perspectives
Jia, X., Gao, Z., & Hu, H. (2020) · Science China Life Sciences · doi:10.1007/s11427-020-1815-6 · Cited by 283 · see citing works
Chen, M.-H., Li, C.-T., Lin, W.-C., Hong, C.-J., Tu, P.-C., Bai, Y.-M., Cheng, C.-M., & Su, T.-P. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.08.078 · Cited by 159 · see citing works
The P2X7 Receptor: Central Hub of Brain Diseases
Andrejew, R., Oliveira-Giacomelli, Á., Ribeiro, D. E., Glaser, T., Arnaud-Sampaio, V. F., Lameu, C., & Ulrich, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00124 · Cited by 162 · see citing works
Nowak, W., Grendas, L. N., Sanmarco, L. M., Estecho, I. G., Arena, Á. R., Eberhardt, N., Rodante, D. E., Aoki, M. P., Daray, F. M., Carrera Silva, E. A., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.10.063 · Cited by 159 · see citing works
Donoso, F., Cryan, J. F., Olavarría‐Ramírez, L., Nolan, Y. M., & Clarke, G. A. (2022) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2581 · Cited by 147 · see citing works
Getachew, B., Aubee, J. I., Schottenfeld, R. S., Csoka, A. B., Thompson, K. M., & Tizabi, Y. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1373-7 · Cited by 137 · see citing works
Neuroinflammation: The central enabler of postoperative cognitive dysfunction
Liu, Y., Yang, W., Xue, J., Chen, J., Liu, S., Zhang, S., Zhang, X., Gu, X., Dong, Y., & Qiu, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115582 · Cited by 136 · see citing works
P2X7 Receptor Signaling in Stress and Depression
Ribeiro, D. E., Roncalho, A. L., Glaser, T., Ulrich, H., Wegener, G., & Joca, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112778 · Cited by 129 · see citing works
The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis
Mi, W., Xia, Y., & Bian, Y. (2019) · Inflammation Research · doi:10.1007/s00011-019-01220-4 · Cited by 128 · see citing works
Recent advances in CNS P2X7 physiology and pharmacology: Focus on neuropsychiatric disorders
Bhattacharya, A. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00030 · Cited by 115 · see citing works
Inflaming sex differences in mood disorders
Rainville, J. R., & Hodes, G. E. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0124-7 · Cited by 106 · see citing works
van Vuren, E. J., Steyn, S. F., Brink, C. B., Möller, M., Viljoen, F. P., & Harvey, B. H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111200 · Cited by 105 · see citing works
Brain region–specific action of ketamine as a rapid antidepressant
Chen, M., Ma, S., Liu, H., Dong, Y., Tang, J., Ni, Z., Tan, Y. J., Duan, C.-C., Li, H., Huang, H., et al. (2024) · Science · doi:10.1126/science.ado7010 · Cited by 103 · see citing works
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
Kopra, E. I., Mondelli, V., Pariante, C. M., & Nikkheslat, N. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211026426 · Cited by 102 · see citing works
Serna-Rodríguez, M. F., Bernal‐Vega, S., de la Barquera, J. A. O.-S., Camacho‐Morales, A., & Pérez‐Maya, A. A. (2022) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2022.577951 · Cited by 101 · see citing works
Mohammadi, A. B., Torbati, M., Farajdokht, F., Sadigh‐Eteghad, S., Fazljou, S. M. B., Vatandoust, S. M., Golzari, S. E., & Mahmoudi, J. (2019) · Brain Research · doi:10.1016/j.brainres.2019.03.020 · Cited by 90 · see citing works
Farooq, R. K., Tanti, A., Ainouche, S., Roger, S., Belzung, C., & Camus, V. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.07.016 · Cited by 83 · see citing works
Bhattacharya, A., Lord, B., Grigoleit, J., He, Y., Fraser, I. C., Campbell, S. N., Taylor, N., Aluisio, L. E., O’Connor, J. C., Papp, M., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0141-6 · Cited by 82 · see citing works
Zhan, Y., Zhou, Y., Zheng, W., Liu, W., Wang, C., Lan, X., Deng, X., Xu, Y., Zhang, B., & Ning, Y. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00933-z · Cited by 81 · see citing works
Namba, M. D., Leyrer-Jackson, J. M., Nagy, E. K., Olive, M. F., & Neisewander, J. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.650785 · Cited by 76 · see citing works
Pathological ATPergic Signaling in Major Depression and Bipolar Disorder
Illés, P., Verkhratsky, A., & Tang, Y. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00331 · Cited by 77 · see citing works
Medeiros, G. C., Gould, T. D., Prueitt, W. L., Nanavati, J., Grunebaum, M. F., Farber, N. B., Singh, B., Selvaraj, S., Machado-Vieira, R., Achtyes, E. D., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01652-1 · Cited by 75 · see citing works
Fu, S., Wang, J., Hao, C., Dang, H., & Jiang, S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05210-6 · Cited by 73 · see citing works
Nikkheslat, N. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100383 · Cited by 71 · see citing works
Xie, L., Gu, Z., Liu, H., Jia, B., Wang, Y., Cao, M., Song, R., Zhang, Z., & Bian, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01251 · Cited by 70 · see citing works
Li, J., Liu, L.-L., Su, W., Wang, B., Zhang, T., Zhang, Y., & Jiang, C. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.11.022 · Cited by 67 · see citing works
Wen, Y., Xu, J., Shen, J., Tang, Z., Li, S., Zhang, Q., Li, J., & Sun, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-023-03860-4 · Cited by 71 · see citing works
Inflammation, stress and depression: An exploration of ketamine’s therapeutic profile
Johnston, J. N., Greenwald, M. S., Henter, I. D., Kraus, C., Mkrtchian, A., Clark, N. G., Park, L. T., Gold, P. W., Zarate, C. A., & Kadriu, B. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103518 · Cited by 66 · see citing works
Flux, M. C., & Lowry, C. A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104578 · Cited by 68 · see citing works
Guo, Y., Xie, J., Li, X., Yuan, Y., Zhang, L., Hu, W., Luo, H., Yu, H., & Zhang, R. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01126 · Cited by 64 · see citing works
An update on NMDA antagonists in depression
Pochwat, B., Nowak, G., & Szewczyk, B. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1643237 · Cited by 65 · see citing works
Duan, C., Zhang, J., Wan, T.-F., Wang, Y., Chen, D., & Liu, L. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112296 · Cited by 66 · see citing works
Han, Q.-Q., Huang, H., Wang, Y., Liu, Y., Pilot, A., Zhu, X., Yu, R., Wang, J., Chen, X., Liu, Q., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.02.013 · Cited by 53 · see citing works
Stress, pain, anxiety, and depression in endometriosis–Targeting glial activation and inflammation
Mokhtari, T., Irandoost, E., & Sheikhbahaei, F. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111942 · Cited by 56 · see citing works
Mechanisms and Therapeutic Targets of Depression After Intracerebral Hemorrhage
Wu, Y., Wang, L., Hu, K., Yu, C., Zhu, Y., Zhang, S., & Shao, A. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00682 · Cited by 49 · see citing works
Gürsel (2018) · doi:10.1016/j.neubiorev.2018.02.005 · Cited by 47 · see citing works
Sun, Y., Yan, T., Gong, G., Li, Y., Zhang, J., Wu, B., Bi, K., & Jia, Y. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107029 · Cited by 47 · see citing works
Cathomas, F., Bevilacqua, L., Ramakrishnan, A., Kronman, H., Costi, S., Schneider, M., Chan, K. L., Li, L., Nestler, E. J., Shen, L., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-021-01712-0 · Cited by 45 · see citing works
The effects of anaesthetics and sedatives on brain inflammation
Dominguini, D., Steckert, A. V., Michels, M., Borges, M. S., Ritter, C., Barichello, T., Thompson, J. P., & Dal‐Pizzol, F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.05.009 · Cited by 44 · see citing works
Mitochondria: A Connecting Link in the Major Depressive Disorder Jigsaw
Sharma, S., & Akundi, R. S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180302120322 · Cited by 42 · see citing works
Neurobiological biomarkers of response to ketamine
Kadriu, B., Ballard, E. D., Henter, I. D., Murata, S., Gerlus, N., & Zarate, C. A. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.05.003 · Cited by 36 · see citing works
Guo, Y., Xie, J., Zhang, L., Yang, L., Ma, J., Bai, Y., Ma, W., Wang, X., Yu, H., Zeng, Y.-Q., et al. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135561 · Cited by 36 · see citing works
Immunoregulation and antidepressant effect of ketamine
Zhang, N., Yao, L., Wang, P., & Liu, Z. (2021) · Translational Neuroscience · doi:10.1515/tnsci-2020-0167 · Cited by 35 · see citing works
Serum miR-221-3p as a new potential biomarker for depressed mood in perioperative patients
Feng, J., Wang, M., Li, M., Yang, J., Jia, J., Liu, L., Zhou, J. F., Zhang, C., & Wang, X. (2019) · Brain Research · doi:10.1016/j.brainres.2019.06.015 · Cited by 34 · see citing works
Ketamine – A New Antidepressant Drug with Anti-Inflammatory Properties
Jóźwiak-Bębenista, M., Sokołowska, P., Wiktorowska‐Owczarek, A., Kowalczyk, E., & Sienkiewicz, M. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001823 · Cited by 32 · see citing works
Ma, W., Li, L., & Xing, S. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146335 · Cited by 32 · see citing works
Mograbi, K. D. M., Suchecki, D., da Silva, S. G., Covolan, L., & Hamani, C. (2020) · Stress · doi:10.1080/10253890.2020.1712355 · Cited by 32 · see citing works
Dong, Y., Wang, X., Zhou, Y., Zheng, Q., Chen, Z., Zhang, H., Sun, Z., Xu, G., & Hu, G. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104741 · Cited by 31 · see citing works
Brain immune cells characterization in UCMS exposed P2X7 knock-out mouse
Troubat, R., Leman, S., Pinchaud, K., Surget, A., Barone, P. R., Roger, S., Guisquet, A. L., Brizard, B., Belzung, C., & Camus, V. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.02.012 · Cited by 33 · see citing works
Frinchi, M., Nuzzo, D., Scaduto, P., Carlo, M. D., Massenti, M. F., Belluardo, N., & Mudò, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-50708-w · Cited by 31 · see citing works
A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics?
Eltokhi, A., & Sommer, I. E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.852506 · Cited by 32 · see citing works
Zhou, Y., Wu, F., Wang, C., Zheng, W., Lan, X., Deng, X., & Ning, Y. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.068 · Cited by 28 · see citing works
NLRP1-Mediated Antidepressant Effect of Ketamine in Chronic Unpredictable Mild Stress Model in Rats
Arıcıoğlu, F., Yalçınkaya, C., Özkartal, C. Ş., Tüzün, E., Şirvancı, S., Küçükali, C. İ., & Utkan, T. (2020) · Psychiatry Investigation · doi:10.30773/pi.2019.0189 · Cited by 27 · see citing works
Ketamine as a prophylactic resilience-enhancing agent
Evers, A. G., Murrough, J. W., Charney, D. S., & Costi, S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.833259 · Cited by 27 · see citing works
Recent Advances in the Mechanisms of Postoperative Neurocognitive Dysfunction: A Narrative Review
Wang, T., Huang, X., Sun, S., Wang, Y., Han, L., Zhang, T., Zhang, T., & Chen, X. (2025) · Biomedicines · doi:10.3390/biomedicines13010115 · Cited by 26 · see citing works
Li, P., Zhang, F., Li, Y., Zhang, C., Yang, Z., Zhang, Y., & Song, C. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211032473 · Cited by 26 · see citing works
Beyond Seizure Control: Treating Comorbidities in Epilepsy via Targeting of the P2X7 Receptor
Gil, B., Smith, J., Tang, Y., Illés, P., & Engel, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042380 · Cited by 26 · see citing works
Ketamine: A Neglected Therapy for Alzheimer Disease
Smalheiser, N. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00186 · Cited by 30 · see citing works
Zhao, J., Zhang, R., Wang, W., Jiang, S., Liang, H., Guo, C., Qi, J., Zeng, H., & Song, H. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109880 · Cited by 25 · see citing works
VanderZwaag, J., Halvorson, T., Dolhan, K., Šimončičová, E., Ben‐Azu, B., & Tremblay, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03772-0 · Cited by 26 · see citing works
Astroglial Mechanisms of Ketamine Action Include Reduced Mobility of Kir4.1-Carrying Vesicles
Stenovec, M., Božić, M., Pirnat, S., & Zorec, R. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02744-1 · Cited by 25 · see citing works
Chen, H., Ma, Y., Chen, M., Chen, J., & Jin, C. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1728 · Cited by 23 · see citing works
Purinergic P2X7 receptor as a potential therapeutic target in depression
Wang, Q., Jin, X., & Guan, W. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115959 · Cited by 22 · see citing works
Smiley, C. E., & Wood, S. K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108212 · Cited by 23 · see citing works
P2X7 Receptor as a Potential Target for Major Depressive Disorder
Huang, Z., & Tan, S. (2021) · Current Drug Targets · doi:10.2174/1389450122666210120141908 · Cited by 20 · see citing works
Molecular pathways of ketamine: A systematic review of immediate and sustained effects on PTSD
Wellington, N. J., Bouças, A. P., Lagopoulos, J., Quigley, B. L., & Kuballa, A. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06756-4 · Cited by 21 · see citing works
Tan, Q., He, L.-Y., He, Z., Liu, W., Zhang, S., Lin, L., Yang, H., & Guan, L. (2021) · Medicinal Chemistry Research · doi:10.1007/s00044-021-02742-5 · Cited by 19 · see citing works
Li, T., Huang, Z., Wang, X., Zou, J., & Tan, S. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2019-0003 · Cited by 19 · see citing works
Peng, F., Fan, J., Ge, T., Liu, Q. Q., & Li, B. J. (2020) · Cell Proliferation · doi:10.1111/cpr.12804 · Cited by 18 · see citing works
Kalkman, H. O. (2023) · Biomedicines · doi:10.3390/biomedicines11030806 · Cited by 18 · see citing works
Fekri, K., Nayebi, A. M., Sadigh‐Eteghad, S., Farajdokht, F., & Mahmoudi, J. (2020) · Neurochemical Journal · doi:10.1134/s181971242002004x · Cited by 19 · see citing works
Gagne, C., Piot, A., & Brake, W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.797577 · Cited by 14 · see citing works
Reflections on the neuroscientific legacy of Jaak Panksepp (1943–2017)
Watt, D. F. (2017) · Neuropsychoanalysis · doi:10.1080/15294145.2017.1376549 · Cited by 18 · see citing works
He, M., Feng, R., Wang, J., Xia, S., Wang, Y., & Zhang, Y. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.950143 · Cited by 17 · see citing works
Murck, H., Lehr, L., & Ježová, D. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13219 · Cited by 17 · see citing works
Cao, Y., Chen, H. L., Tan, Y., Yu, X., Xiao, C., Li, Y. Q., Reilly, J., He, Z., & Shu, X. (2023) · Physiology & Behavior · doi:10.1016/j.physbeh.2023.114415 · Cited by 17 · see citing works
Yu, Y., He, X., Wang, Y., Zhang, J., Tang, C., & Rong, P. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136562 · Cited by 16 · see citing works
Kristóf, Z., Eszlári, N., Sütöri, S., Gál, Z., Török, D., Baksa, D., Petschner, P., Sperlágh, B., Anderson, I. M., Deakin, J. F. W., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252766 · Cited by 16 · see citing works
Misztak, P., Sowa-Kućma, M., Pańczyszyn-Trzewik, P., Szewczyk, B., & Nowak, G. (2021) · Molecules · doi:10.3390/molecules27010022 · Cited by 15 · see citing works
Han, W., Zheng, Y., Wang, L., & An, C. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578172 · Cited by 15 · see citing works
Effect of General Anesthetic Agents on Microglia
Yang, Y., Hang, W., Li, J., Liu, T., Hu, Y., Fang, F., Yan, D., McQuillan, P. M., Wang, M., & Hu, Z. (2023) · Aging and Disease · doi:10.14336/ad.2023.1108 · Cited by 14 · see citing works
Kang, M. J. Y., & Vázquez, G. H. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.047 · Cited by 13 · see citing works
Hao, Y., Niu, H., An, S., Wang, M., & Wang, Z. (2018) · Journal of Immunology Research · doi:10.1155/2018/3256908 · Cited by 13 · see citing works
Scott, K. A., Phan, T., Boukelmoune, N., Heijnen, C. J., & Dantzer, R. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2022.10.017 · Cited by 13 · see citing works
Wu, G.-H., Guo, Q.-H., Xu, X., Lin, J.-C., You, G.-T., Lin, C., & Zhang, L.-C. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01236-0 · Cited by 12 · see citing works
Magnesium and ketamine in the treatment of depression.
Górska, N., Słupski, J., Szałach, Ł. P., Włodarczyk, A., Szarmach, J., Jakuszkowiak‐Wojten, K., Gałuszko‐Węgielnik, M., Wilkowska, A., Wiglusz, M. S., & Cubała, W. J. (2019) · PubMed · Cited by 12 · see citing works
Wang, Y., Yang, Q., Chen, C., Yao, Y., Yuan, X., & Zhang, K. (2024) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-024-01913-w · Cited by 11 · see citing works
Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies
Kositsyn, Y. M., de Abreu, M. S., Kolesnikova, T. O., Lagunin, A. A., Poroikov, V., Harutyunyan, H. S., Yenkoyan, K. B., & Kalueff, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119482 · Cited by 11 · see citing works
Edem, E. E., Anyanwu, C.-K. C., Nebo, K. E., Akinluyi, E. T., Fafure, A. A., Ishola, A. O., & Enye, L. A. (2021) · Psychopharmacology · doi:10.1007/s00213-021-06021-4 · Cited by 10 · see citing works
Flowers, J. C., Vetter, P. E., Wiles, M. J., Roh, S. H., Black, E. R., Bouckova, E., Wustrau, M. H., Lee, R., Lee, S.-H., & Kim, S. (2025) · The FASEB Journal · doi:10.1096/fj.202501763r · Cited by 9 · see citing works
Chronic restraint stress alters rat behavior depending on sex and duration of stress
Pansarim, V., Leite‐Panissi, C. R. A., & Schmidt, A. (2023) · Behavioural Processes · doi:10.1016/j.beproc.2023.104856 · Cited by 9 · see citing works
Nouri, M., Farajdokht, F., Torbati, M., Ranjbar, F., Hamedyazdan, S., Sadigh‐Eteghad, S., & Araj‐Khodaei, M. (2019) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.95438 · Cited by 9 · see citing works
Rice bran supplement ameliorates chronic restraint stress-induced depression-like behaviors in mice
Kim, M., Yoon, M., Cho, S., Kim, M. J., & Um, M. Y. (2024) · Food & Function · doi:10.1039/d4fo00718b · Cited by 8 · see citing works
Lamontagne, S. J., Ballard, E. D., & Zarate, C. A. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100450 · Cited by 9 · see citing works
Wenhui, Z., Li, W., Jiang, J., Wang, D., Mao, X., Zhang, J., Zhang, X., Chang, J., Yao, P., Yang, X., et al. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1071327 · Cited by 8 · see citing works
Serotonergic neurons in the treatment of mood disorders: The dialogue with astrocytes
Charvériat, M., & Guiard, B. P. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.006 · Cited by 7 · see citing works
Involvement of proBDNF in Monocytes/Macrophages with Gastrointestinal Disorders in Depressive Mice
Yu, Y.-Q., Zhang, Y., Wang, Z., Liu, Y., Li, H., Zhou, X., Hu, Z., & Dai, R. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00235-8 · Cited by 6 · see citing works
- Authors
- Tan, S., Wang, Y., Chen, K., Long, Z., & Zou, J.
- Affiliations
- University of South China (CN)
- Venue
- Biological & Pharmaceutical Bulletin
- Publisher
- Pharmaceutical Society of Japan
- Published
- 2017
- Volume
- 40
- Issue
- 8
- Pages
- 1260-1267
- ISSN
- 0918-6158 (ISSN-L)
- 1347-5215
- OpenAlex
- W2741144353
- Cited by
- 142
- References
- 42
- Citations by year
- 2026: 3 · 2025: 16 · 2024: 10 · 2023: 19 · 2022: 23 · 2021: 19 · 2020: 19 · 2019: 20 · 2018: 12 · 2017: 1
- FWCI
- 9.92
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Locations
- Biological and Pharmaceutical Bulletin (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of South China
- Construct Program of the Key Discipline in Hunan Province
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- ketamine, rapid antidepressant effects, chronic restraint stress, depression-like behavior, neuroinflammation, hippocampus, microglial activation, inflammatory cytokines, P2X7 receptor, IL-1β, TNF-α, interleukin-6, antidepressant mechanism
- MeSH terms
- Animals, Antidepressive Agents, Behavior, Animal, Corticosterone, Food Preferences, Hippocampus, Ketamine, Restraint, Physical, Stress, Psychological, Sucrose, Swimming, Down-Regulation, Cytokines, Excitatory Amino Acid Antagonists, p38 Mitogen-Activated Protein Kinases, Toll-Like Receptor 4, Mice, Receptors, Purinergic P2X7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review